Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06671002 · ClinicalTrials.gov registry record · Phase 4

Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial

A Phase 4 study of Surgery and Pain, Postoperative, sponsored by University of Michigan.

Recruiting
Registry status
Phase 4
Development phase
900
Enrollment target
4
Study locations

NCT06671002: Recruiting Phase 4 study of Surgery and Pain, Postoperative, sponsored by University of Michigan.

NCT06671002 is a Phase 4 study of Surgery and Pain, Postoperative that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 900 participants, below the 52,844-participant average among 120 other Surgery trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06671002, a Phase 4 study of Surgery and Pain, Postoperative, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
Phase 4
Development phase
900 participants
Enrollment target
4
Study locations

Study Summary

This trial is being completed to compare two commonly used options to treat pain after discharge from surgery. Participants that undergo tonsil removal, gallbladder removal, and knee scope will be eligible to enroll. Eligible participants will be randomized to prescription of 1 of 2 groups of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) plus acetaminophen or low dose opioids with the NSAIDs plus acetaminophen. The key question the study seeks to answer is which option will have the best outcomes and with the fewest side effects?

Primary Outcome

This is a one question survey in which the worst pain intensity recorded (0-10 being the worst) will be used.

Interventions

  • DRUG Acetaminophen
  • DRUG Ibuprofen
  • DRUG NSAID
  • DRUG Opioid

Study Locations (4)

California

  • Children's Hospital Los Angeles (CHLA) - Los Angeles
  • Lucile Packard Children's Hospital Stanford - Palo Alto

Michigan

  • University of Michigan - Ann Arbor

Ohio

  • Nationwide Children's (NCH) - Columbus

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2025-01-10
Est. Completion 2027-10-31
Phase Phase 4
University of Michigan

1,327 total trials

What NCT06671002 shows while recruiting

NCT06671002 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 52,844-participant average among 120 other Surgery trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 4 interventions - of which Acetaminophen is the first listed.

NCT06671002 reports a single indexed study location in California, Michigan, Ohio.

Frequently Asked Questions

What is clinical trial NCT06671002 about?

NCT06671002 is a clinical study titled "Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial". This trial is being completed to compare two commonly used options to treat pain after discharge from surgery. Participants that undergo tonsil removal, gallbladder removal, and knee scope will be eligible to enroll. Eligible participants will be randomized to prescription of 1 of 2 groups of medica...

What is the current status of trial NCT06671002?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 900 participants. The study started on 2025-01-10. Estimated completion is 2027-10-31.

What conditions does trial NCT06671002 study?

This clinical trial studies the following conditions: Surgery, Pain, Postoperative.

What interventions are being tested in trial NCT06671002?

The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), NSAID (DRUG), Opioid (DRUG).

Who is sponsoring clinical trial NCT06671002?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06671002 being conducted?

This trial has 4 study locations across California, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06671002's enrollment target sits among peer trials

900 13th of 120 higher than 107 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06671002, the US trial registry maintained by the National Library of Medicine. NCT06671002 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.